JP2024508749A5 - - Google Patents
Info
- Publication number
- JP2024508749A5 JP2024508749A5 JP2023549562A JP2023549562A JP2024508749A5 JP 2024508749 A5 JP2024508749 A5 JP 2024508749A5 JP 2023549562 A JP2023549562 A JP 2023549562A JP 2023549562 A JP2023549562 A JP 2023549562A JP 2024508749 A5 JP2024508749 A5 JP 2024508749A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- binding
- bispecific molecule
- antigen
- trbc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150232P | 2021-02-17 | 2021-02-17 | |
| US63/150,232 | 2021-02-17 | ||
| PCT/US2022/016423 WO2022177889A1 (en) | 2021-02-17 | 2022-02-15 | Methods and materials for treating clonal t cell expansions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508749A JP2024508749A (ja) | 2024-02-28 |
| JP2024508749A5 true JP2024508749A5 (https=) | 2025-02-17 |
Family
ID=80595091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549562A Pending JP2024508749A (ja) | 2021-02-17 | 2022-02-15 | クローンｔ細胞増殖を処置するための方法および材料 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240124608A1 (https=) |
| EP (1) | EP4294841A1 (https=) |
| JP (1) | JP2024508749A (https=) |
| CN (1) | CN117561277A (https=) |
| AU (1) | AU2022222679A1 (https=) |
| CA (1) | CA3211203A1 (https=) |
| WO (1) | WO2022177889A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120076829A (zh) | 2022-10-18 | 2025-05-30 | 明治制果药业株式会社 | T细胞肿瘤的治疗剂 |
| WO2025007013A2 (en) * | 2023-06-28 | 2025-01-02 | The Johns Hopkins University | Trbc targeting antibody-drug conjugates |
| WO2025220689A1 (ja) * | 2024-04-17 | 2025-10-23 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | Ｔ細胞機能不全のｔ細胞性腫瘍患者に有効な二重特異性抗体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3241561T3 (da) | 2014-03-05 | 2025-06-30 | Autolus Ltd | Konjugeret antistof eller bispecifik t-celle-engager, som selektivt binder enten tcr-beta konstant region 1 (trbc1) eller trbc2 |
| GB201709203D0 (en) * | 2017-06-09 | 2017-07-26 | Autolus Ltd | Antigen-binding domain |
| GB201817172D0 (en) * | 2018-10-22 | 2018-12-05 | Autolus Ltd | Antibody |
| GB201817822D0 (en) * | 2018-10-31 | 2018-12-19 | Autolus Ltd | Binding domain |
-
2022
- 2022-02-15 EP EP22706972.1A patent/EP4294841A1/en active Pending
- 2022-02-15 US US18/277,631 patent/US20240124608A1/en active Pending
- 2022-02-15 CN CN202280028887.8A patent/CN117561277A/zh active Pending
- 2022-02-15 AU AU2022222679A patent/AU2022222679A1/en active Pending
- 2022-02-15 CA CA3211203A patent/CA3211203A1/en active Pending
- 2022-02-15 JP JP2023549562A patent/JP2024508749A/ja active Pending
- 2022-02-15 WO PCT/US2022/016423 patent/WO2022177889A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024508749A5 (https=) | ||
| JP2023551535A5 (https=) | ||
| JP2021530987A5 (https=) | ||
| JP2022061993A5 (https=) | ||
| US20210355217A1 (en) | T-cell receptor constant region 1 antibody or t-cell receptor constant region 2 antibody | |
| JP2020537644A5 (https=) | ||
| CN110741018A (zh) | 抗原结合结构域 | |
| JP2020529830A5 (https=) | ||
| JP2023526774A5 (https=) | ||
| JP2021523122A5 (https=) | ||
| JP2023519099A5 (https=) | ||
| JP2021512107A5 (https=) | ||
| JP2022544825A5 (https=) | ||
| JP2023522857A5 (https=) | ||
| Kamakura et al. | Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation | |
| KR20230086674A (ko) | 파킨슨 질환의 치료 | |
| JP7704748B2 (ja) | 逐次抗ｃｄ１９治療 | |
| JP2024508749A (ja) | クローンｔ細胞増殖を処置するための方法および材料 | |
| JP2021524451A5 (https=) | ||
| HUE026740T2 (en) | Treatment of Multiple Sclerosis (MS) with Campath-1H | |
| JP2024513054A5 (https=) | ||
| Vartzelis et al. | Rituximab as rescue therapy for aggressive pediatric multiple sclerosis | |
| Dinov et al. | Current and emerging therapies for autoimmune encephalitis | |
| Hewitt et al. | Overlap of generalized morphea and eosinophilic fasciitis after recreational exposure to epoxy resin | |
| JP2023540618A5 (https=) |